{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "35474738",
  "DateCompleted": {
    "Year": "2022",
    "Month": "04",
    "Day": "28"
  },
  "DateRevised": {
    "Year": "2022",
    "Month": "12",
    "Day": "07"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2022",
        "Month": "03",
        "Day": "15"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "100579",
      "10.1016/j.xcrm.2022.100579"
    ],
    "Journal": {
      "ISSN": "2666-3791",
      "JournalIssue": {
        "Volume": "3",
        "Issue": "3",
        "PubDate": {
          "Year": "2022",
          "Month": "Mar",
          "Day": "15"
        }
      },
      "Title": "Cell reports. Medicine",
      "ISOAbbreviation": "Cell Rep Med"
    },
    "ArticleTitle": "Enhanced immunity after Ad26.COV2.S vaccine breakthrough infection.",
    "Pagination": {
      "StartPage": "100579",
      "MedlinePgn": "100579"
    },
    "Abstract": {
      "AbstractText": [
        "A study by Kitchin, Richardson et\u00a0al. finds that breakthrough infection with the SARS-CoV-2 Delta variant in Ad26.COV2.S-vaccinated individuals induces strong neutralizing antibody responses against multiple variants, including the Omicron variant."
      ],
      "CopyrightInformation": "\u00a9 2022 The Author(s)."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Department of Surgery, Duke University Medical Center, Durham, NC, USA."
          }
        ],
        "LastName": "Montefiori",
        "ForeName": "David C",
        "Initials": "DC"
      }
    ],
    "PublicationTypeList": [
      "News",
      "Comment"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "United States",
    "MedlineTA": "Cell Rep Med",
    "NlmUniqueID": "101766894",
    "ISSNLinking": "2666-3791"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "JT2NS6183B",
      "NameOfSubstance": "Ad26COVS1"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antibodies, Viral"
    },
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Viral Vaccines"
    }
  ],
  "SupplMeshList": [
    "SARS-CoV-2 variants"
  ],
  "CommentsCorrectionsList": [
    {
      "RefSource": "Cell Rep Med. 2022 Feb 10;3(3):100535",
      "PMID": "35474744"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Ad26COVS1"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Antibodies, Viral"
    },
    {
      "QualifierName": [
        "prevention & control"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Viral Vaccines"
    }
  ],
  "CoiStatement": "The author declares no competing interests."
}